Zhehan Shen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhehan Shen has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Ruokun Li
Department of Radiology, Ruijin Hospital, College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publications - Wanmin Liu
Department of Radiology Ruijin Hospital College of Health Science and Technology Shanghai Jiao Tong University School of Medicine Shanghai China
2 shared publications - Wenjie Zou
Department of Radiology School of Medicine Tongji Hospital Tongji University Shanghai China
2 shared publications - Xiaoming Li
T Magnetic Resonance Translational Medicine Research Center Department of Radiology The First Affiliated Hospital of Army Medical University Chongqing China
2 shared publications Yiman Li
T Magnetic Resonance Translational Medicine Research Center Department of Radiology The First Affiliated Hospital of Army Medical University Chongqing China
2 shared publicationsChengyan Wang
1 shared publication
Latest Publications
- Open Access
- 1 November 2026
- Published by Wiley in Advanced Science
A CT Lesion Foundation Model for Non‐Invasive Assessment of Hepatocellular Carcinoma Aggressiveness and Prediction of Recurrence Risk
Hepatocellular carcinoma (HCC) remains a leading cause of cancer‐related mortality worldwide, with high recurrence rates following curative resection. Accurate non‐invasive assessment of tumor aggressiveness and recurrence risk is critical for surgical decision‐making and postoperative surveillance, yet remains challenging with conventional imaging modalities. Here, we developed a CT lesion foundation model (LFM), trained via self‐supervised learning on 32,120 generic lesion and 6,387 HCC‐specific CT patches to capture transferable intra‐lesional imaging phenotypes. Across one internal and two external validation cohorts, the sequentially pretrained LFM (LFM‐Seq) achieved area under the curve values of 0.916, 0.846, and 0.920 for microvascular invasion (MVI) assessment, and 0.833, 0.885 and 0.795 for pathological grade assessment. The model remained robust under scenarios of limited training data and tumor localization perturbations. Furthermore, LFM‐Seq‐derived risk scores stratified recurrence‐free survival (RFS), yielding an externally validated C‐index of 0.701, and remained independently associated with RFS after adjusting for clinicopathological factors. Exploratory biological interpretability analyses showed that LFM‐Seq‐derived risk phenotypes were associated with suppressed lymphocyte‐related immune programs. These results suggest that CT lesion foundation models can support non‐invasive and robust characterization of HCC aggressiveness, recurrence risk stratification and discovery of interpretable prognostic imaging biomarkers.
- 1 November 2026
- Published by Wiley in Advanced Science
Open AccessA CT Lesion Foundation Model for Non‐Invasive Assessment of Hepatocellular Carcinoma Aggressiveness and Prediction of Recurrence Risk
Hepatocellular carcinoma (HCC) remains a leading cause of cancer‐related mortality worldwide, with high recurrence rates following curative resection. Accurate non‐invasive assessment of tumor aggressiveness and recurrence risk is critical for surgical decision‐making and postoperative surveillance, yet remains challenging with conventional imaging modalities. Here, we developed a CT lesion foundation model (LFM), trained via self‐supervised learning on 32,120 generic lesion and 6,387 HCC‐specific CT patches to capture transferable intra‐lesional imaging phenotypes. Across one internal and two external validation cohorts, the sequentially pretrained LFM (LFM‐Seq) achieved area under the curve values of 0.916, 0.846, and 0.920 for microvascular invasion (MVI) assessment, and 0.833, 0.885 and 0.795 for pathological grade assessment. The model remained robust under scenarios of limited training data and tumor localization perturbations. Furthermore, LFM‐Seq‐derived risk scores stratified recurrence‐free survival (RFS), yielding an externally validated C‐index of 0.701, and remained independently associated with RFS after adjusting for clinicopathological factors. Exploratory biological interpretability analyses showed that LFM‐Seq‐derived risk phenotypes were associated with suppressed lymphocyte‐related immune programs. These results suggest that CT lesion foundation models can support non‐invasive and robust characterization of HCC aggressiveness, recurrence risk stratification and discovery of interpretable prognostic imaging biomarkers.
- Open Access
- 18 October 2026
- Published by Wiley in Advanced Science
Foundation Model‐Enabled Pathology‐Informed MRI Model for Preoperative Prediction of Vessels Encapsulating Tumor Clusters in Resectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
Vessels encapsulating tumor clusters (VETC) are an aggressive vascular phenotype of hepatocellular carcinoma that is usually determined after surgery. A foundation model‐enabled framework for pathology‐informed VETC prediction on pretreatment magnetic resonance imaging (MRI), termed PIVOT, uses paired preoperative multiparametric MRI, postoperative hematoxylin and eosin whole‐slide images, and CD34 immunohistochemistry during model development, while inference requires only preoperative MRI. PIVOT‐MRI uses morphologic and vascular embedding alignment, and PIVOT‐Clinical combines the PIVOT‐MRI score with tumor size and alpha‐fetoprotein. The multicenter retrospective study includes 2052 patients in a training cohort, an internal test cohort, and four external validation cohorts. PIVOT‐MRI achieves an area under the receiver operating characteristic curve of 0.887 in the internal test cohort and 0.839‐0.861 across external cohorts. PIVOT‐Clinical increases the internal‐test area under the curve to 0.904 and PIVOT‐Clinical‐defined groups are associated with different two‐year recurrence risks. Removing both histopathologic alignment branches results in the largest ablation‐related performance decrease. Exploratory radiotranscriptomic analyses showed that higher PIVOT‐MRI scores were associated with angiogenesis‐related, endothelial, and proliferative transcriptional programs. PIVOT enables noninvasive preoperative assessment of pathology‐defined vascular aggressiveness in resectable hepatocellular carcinoma while preserving an MRI‐only clinical inference pathway.
- 18 October 2026
- Published by Wiley in Advanced Science
Open AccessFoundation Model‐Enabled Pathology‐Informed MRI Model for Preoperative Prediction of Vessels Encapsulating Tumor Clusters in Resectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
Vessels encapsulating tumor clusters (VETC) are an aggressive vascular phenotype of hepatocellular carcinoma that is usually determined after surgery. A foundation model‐enabled framework for pathology‐informed VETC prediction on pretreatment magnetic resonance imaging (MRI), termed PIVOT, uses paired preoperative multiparametric MRI, postoperative hematoxylin and eosin whole‐slide images, and CD34 immunohistochemistry during model development, while inference requires only preoperative MRI. PIVOT‐MRI uses morphologic and vascular embedding alignment, and PIVOT‐Clinical combines the PIVOT‐MRI score with tumor size and alpha‐fetoprotein. The multicenter retrospective study includes 2052 patients in a training cohort, an internal test cohort, and four external validation cohorts. PIVOT‐MRI achieves an area under the receiver operating characteristic curve of 0.887 in the internal test cohort and 0.839‐0.861 across external cohorts. PIVOT‐Clinical increases the internal‐test area under the curve to 0.904 and PIVOT‐Clinical‐defined groups are associated with different two‐year recurrence risks. Removing both histopathologic alignment branches results in the largest ablation‐related performance decrease. Exploratory radiotranscriptomic analyses showed that higher PIVOT‐MRI scores were associated with angiogenesis‐related, endothelial, and proliferative transcriptional programs. PIVOT enables noninvasive preoperative assessment of pathology‐defined vascular aggressiveness in resectable hepatocellular carcinoma while preserving an MRI‐only clinical inference pathway.
- Open Access
- 2 October 2026
- Published by Springer Nature in npj Precision Oncology
MAVEN: an automated multimodal framework for predicting VETC and early recurrence in HCC
- 2 October 2026
- Published by Springer Nature in npj Precision Oncology
Open AccessMAVEN: an automated multimodal framework for predicting VETC and early recurrence in HCC
- 16 September 2025
- Published by Elsevier in Medical Image Analysis
- Vol. 107 (Pt A) , 103790
Correlation Routing Network for Explainable Lesion Classification in Multi-Parametric Liver MRI
- 16 September 2025
- Published by Elsevier in Medical Image Analysis
- Vol. 107 (Pt A) , 103790
Correlation Routing Network for Explainable Lesion Classification in Multi-Parametric Liver MRI